Digital health—Switzerland—Q&A guide

The following Life Sciences practice note provides comprehensive and up to date legal information covering:

  • Digital health—Switzerland—Q&A guide
  • 1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?
  • 2. How would you describe the investment climate for digital health technologies in your jurisdiction, including any noteworthy challenges?
  • 3. What are the most notable recent deals in the digital health sector in your jurisdiction?
  • 4. What due diligence issues should investors address before acquiring a stake in digital health ventures?
  • 5. What financing structures are commonly used by digital health ventures in your jurisdiction? Are there any notable government financing or other support initiatives to promote development of the digital health space?
  • 6. What principal legislation governs the digital health sector in your jurisdiction?
  • 7. Which notable regulatory and enforcement bodies have jurisdiction over the digital health sector?
  • 8. What licensing and authorisation requirements and procedures apply to the provision of digital health products and services in your jurisdiction?
  • 9. Is there any notable ‘soft’ law or guidance governing digital health?
  • More...

Digital health—Switzerland—Q&A guide

This Practice Note contains a jurisdiction-specific Q&A guide to digital health in Switzerland published as part of the Lexology Getting the Deal Through series by Law Business Research (published: June 2021).

Authors: Lenz & Staehelin—Peter Ling; Sevan Antreasyan; Leo Rusterholz; Federico Trabaldo Togna

1. Who are the key players active in your local digital health market and what are the most prominent areas of innovation?

There is a very active investors' scene in Switzerland, composed of both traditional VC and PE funds, as well as major industrial players. Academic institutions with strong technological research capabilities (eg, EPFL in Lausanne or ETH in Zurich) are also major actors in the local digital health market. Supporting a practical application of science and technology, these academic institutions foster the emergence of a vivid and innovative start-up ecosystem through outlicensing of their research products to early-stage companies. Local start-up incubators (eg, Fongit in Geneva, EPFL Innovation Park in Lausanne, Bio-Technopark in Schlieren/Zurich) or government-driven programmes (eg, InnoSuisse), although not exclusively focused on the digital health industry, play also a vital role in this market, by providing an essential (material, human and financial) support to companies, at an early stage of their development.

Two prominent areas of innovation in the local digital health market are (1) digital medical devices (eg, medical software) and (2) wearables and biosensors (eg, monitoring the health

Popular documents